Novel pathophysiological insights into CAR-T cell associated neurotoxicity

Area of Science:

• Oncology
• Immunology
• Cell Therapy

Background:

• Chimeric antigen receptor (CAR) T-cell therapy offers a novel approach for advanced hematological malignancies.
• CAR T-cell therapy harnesses cytotoxic T-cell activity against tumor cells but can induce severe toxicities.

Purpose of the Study:

• To review the current understanding of immune cell-associated neurological syndrome (ICANS) following CAR T-cell therapy.
• To highlight novel findings and identify current knowledge gaps regarding ICANS.

Main Methods:

• Literature review focusing on CAR T-cell therapy and associated toxicities.
• Analysis of mechanisms implicated in ICANS development.

Main Results:

• ICANS is a significant, potentially fatal toxicity associated with CAR T-cell therapy.
• Potential ICANS mechanisms include cytokine surge, off-tumor targeting (e.g., CD19), and vascular leak.

Conclusions:

• While CAR T-cell therapy is a breakthrough, managing toxicities like ICANS is critical.
• Further research into ICANS mechanisms and development of better toxicity control tools are needed.